Short-term evolution of HIV-1 viraemia and CD4+ cell counts in patients who have a primary mutation to zidovudine

AIDS

Volumn 12, Issue 4, 1998, Pages 395-398

  Rubio, Amalia ^a   Leal, Manuel ^a   Rey, Concha ^a   Pineda, Juan Antonio ^a   Sanchez Quijano, Armando ^a   Lissen, Eduardo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Antiretroviral drug; Epidemiology; Mutation; Primary resistance; Viral genotype; Viral load

Indexed keywords

CD4 ANTIGEN; ZIDOVUDINE;

ADULT; ARTICLE; CODON; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STRUCTURAL GENE; T LYMPHOCYTE; VIREMIA; VIRUS LOAD;

EID: 0032485447     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199804000-00008     Document Type: Article

References (13)

1. Hirschel B, Kinloch S, Hoehn B, et al.: Controlled trial of zidovudine (Z) in primary HIV infection (PHI). 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, October 1994 [abstract 156].
2. De Ronde A, Schuurman R, Goudsmit J, Van den Hoek A, Boucher C: First case of new infection with zidovudine-resistant HIV-1 among prospectively studied intravenous drug users and homosexual men in Amsterdam, The Netherlands [letter]. AIDS 1996, 10:231-232.
3. Imrie A, Carr A, Duncombe C, et al.: Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. J Infect Dis 1996, 174:195-198.
4. Rubio A, Leal M, Pineda JA, et al.: Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996 [letter]. AIDS 1997, 11:1184-1186.
5. Erice A, Mayers DL, Strike DG, et al.: Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med 1993, 328:1163-1165.
6. Masquelier B, Lemoigne E, Pellegrin I, Douard D, Sandler B, Fleury HJA: Primary infection with zidovudine-resistant HIV. N Engl J Med 1993, 329:1123-1124.
7. Angarano G, Monno L, Appice A, et al.: Transmission of zidovudine-resistant HIV-1 through heterosexual contacts [letter]. AIDS 1994, 8:1013-1014.
8. Cooper DA, Gatell JM, Kroon S, et al.: European-Australian collaborative group: zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. N Engl J Med 1993, 329:297-303.
9. 6/1, results of the Zidon trial. AIDS 1995, 9:1025-1035.
10. Larder BA, Boucher CAB: PCR detection of human immunodeficiency virus drug resistance mutations. In Diagnostic Molecular Microbiology: Principles and Applications. Edited by Persing DH, Smith TF, Tenover FC, White TJ, Washington, DC: American Society for Microbiology; 1993:527-533.
11. D'Aquila R, Johnson V, Welles S, et al.: Zidovudine resistance and HIV type 1 disease progression during antiretroviral therapy. Ann Intern Med 1995, 122:401-408.
12. Calderón EJ, Torres Y, Medrano FJ, et al.: Emergence and clinical relevance of mutations associated with zidovudine resistance in asymptomatic HIV-1 infected patients. Eur J Clin Microbiol Infect Dis 1995, 14:512-519.
13. Veenstra J, Schurman R, Cornelissen M, et al.: Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus. Clin Infect Dis 1995, 21:556-560.